ClinicalTrials.Veeva

Menu

Predicting Location and Extent of Prostate Cancer Using Micro-Ultrasound Imaging

Stanford University logo

Stanford University

Status

Active, not recruiting

Conditions

Prostate Cancer

Treatments

Device: ExactVu

Study type

Interventional

Funder types

Other

Identifiers

NCT04981223
IRB-58101
NCI-2022-05158 (Registry Identifier)

Details and patient eligibility

About

The goal of this study is to use a clinical micro-ultrasound to systematically image the prostate before biopsy or surgery. The images from the ultrasound system will be saved and compared to other imaging modalities and pathology in order to develop better tools.

Enrollment

95 patients

Sex

Male

Ages

18 to 89 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Scheduled for MR-US fusion prostate biopsy or radical prostatectomy
  • Agree to consent to the study

Exclusion criteria

  • Does not agree to consent.

Trial design

Primary purpose

Diagnostic

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

95 participants in 1 patient group

ExactVu Imaging
Experimental group
Description:
EV29L transducer will be inserted in the subject's rectum. Cine sweeps will be performed to save images of: 1. The entire prostate from posterior to anterior (may require 2 sweeps to cover base and apex) 2. The peripheral zone using the highest zoom setting (30mm depth) on the system (may require 2 sweeps to cover base and apex). Analysis of these images will be performed after surgery but before prostatectomy
Treatment:
Device: ExactVu

Trial documents
2

Trial contacts and locations

1

Loading...

Central trial contact

Ned U Realiza

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems